These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1586108)

  • 1. Screening hospital employees for measles immunity is more cost effective than blind immunization.
    Sellick JA; Longbine D; Schifeling R; Mylotte JM
    Ann Intern Med; 1992 Jun; 116(12 Pt 1):982-4. PubMed ID: 1586108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy.
    Stover BH; Adams G; Kuebler CA; Cost KM; Rabalais GP
    Infect Control Hosp Epidemiol; 1994 Jan; 15(1):18-21. PubMed ID: 8133004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of measles susceptibility in hospital staff. Evidence to support expanding the recommendations of the Immunization Practices Advisory Committee.
    Schwarcz S; McCaw B; Fukushima P
    Arch Intern Med; 1992 Jul; 152(7):1481-3. PubMed ID: 1627028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of measles containment in an ambulatory pediatric clinic.
    Wendorf KA; Kay M; Ortega-Sanchez IR; Munn M; Duchin J
    Pediatr Infect Dis J; 2015 Jun; 34(6):589-93. PubMed ID: 25973936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles immunity among community hospital employees.
    Houck P; Scott-Johnson G; Krebs L
    Infect Control Hosp Epidemiol; 1991 Nov; 12(11):663-8. PubMed ID: 1753081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness model for analyzing two varicella vaccination strategies.
    Gayman J
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S4-8. PubMed ID: 9872686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles: lessons from an outbreak.
    Gurevich I; Barzarga RA; Cunha BA
    Am J Infect Control; 1992 Dec; 20(6):319-25. PubMed ID: 1492697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevaccination serologic screening for measles in health care workers.
    Subbarao EK; Amin S; Kumar ML
    J Infect Dis; 1991 Apr; 163(4):876-8. PubMed ID: 1901334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity in employees of a multihospital healthcare provider.
    Wright LJ; Carlquist JF
    Infect Control Hosp Epidemiol; 1994 Jan; 15(1):8-11. PubMed ID: 8133012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits, risks and costs of immunization for measles, mumps and rubella.
    White CC; Koplan JP; Orenstein WA
    Am J Public Health; 1985 Jul; 75(7):739-44. PubMed ID: 3923849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
    J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of hospital infection control policies and employee measles cases during Los Angeles County's measles epidemic, 1987 to 1989.
    Enguidanos R; Mascola L; Frederick P
    Am J Infect Control; 1992 Dec; 20(6):301-4. PubMed ID: 1492693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a rubella screening program for hospital employees: a five-year review (1986-1990).
    Fraser V; Spitznagel E; Medoff G; Dunagan WC
    Am J Epidemiol; 1993 Nov; 138(9):756-64. PubMed ID: 8237990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness evaluation of measles immunization strategies on a college campus.
    Shlian DM; Matchar D; Seymann GB
    Fam Pract Res J; 1991 Jun; 11(2):193-207. PubMed ID: 1905455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial measles infection in a pediatric hospital during a community-wide epidemic.
    Rivera ME; Mason WH; Ross LA; Wright HT
    J Pediatr; 1991 Aug; 119(2):183-6. PubMed ID: 1861204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.